{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:47:11Z","timestamp":1792108031428,"version":"4.4.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":283,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of molecular alterations in predicting local and distant progression following brain metastasis resection is poorly understood. In this study, we investigated clinical and molecular predictors of intracranial progression following brain metastasis resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of 228 patients who underwent brain metastasis resection at the University of Pittsburgh Medical Center was performed. Tumor specimens underwent next-generation sequencing using the UPMC Oncomine Comprehensive Assay. Bootstrap forest analysis was used to identify top genetic predictors by variable importance for local and distant progression. Cox proportional hazards models were used to identify independent predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Local progression occurred in 110 patients (48.2%) and distant progression in 98 patients (43%). The most frequent genetic alterations were TP53 mutations (61.6%), KRAS mutations (31.2%), and CDKN2A\/B copy number alterations (24.6%, 23.2%). For local progression, bootstrap forest analysis identified PTEN, STK11, KRAS, FGF3, and ATM alterations as top predictors. On multivariable analysis adjusting for primary malignancy type, independent predictors of local progression included RB1 mutations (HR 3.03, P\u2009=\u2009.003), PTEN copy number alterations (HR 0.25, P\u2009=\u2009.02), subtotal resection (HR 2.1, P\u2009=\u2009.04), and postoperative systemic therapy (HR 0.4, P\u2009=\u2009.002). For distant progression, PTEN, TERT, STK11, CDKN2AB, and TP53 alterations were top predictors. Postoperative systemic therapy (HR 0.45, P\u2009=\u2009.01) was the only independent predictor of distant progression in multivariable analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that integrating molecular profiling with clinical factors may contribute to intracranial progression risk stratification after brain metastasis resection, though expansion of the dataset with histology-stratified analyses is warranted to confirm these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag228","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:45:41Z","timestamp":1791632741000},"source":"Crossref","is-referenced-by-count":0,"title":["Genomic and clinical determinants of local and distant intracranial progression following surgical resection of brain metastases"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5315-8362","authenticated-orcid":false,"given":"Neslihan Nisa","family":"Gecici","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Habib","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Hamza","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged T","family":"Ghoche","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivka R","family":"Colen","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-0829","authenticated-orcid":false,"given":"Kalil G","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-5887","authenticated-orcid":false,"given":"Pascal O","family":"Zinn","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"2026101519013117900_vdag228-B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","article-title":"Epidemiology of metastatic brain tumors","volume":"22","author":"Fox","year":"2011","journal-title":"Neurosurg Clin N Am"},{"key":"2026101519013117900_vdag228-B2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/neuonc\/now127","article-title":"Updates in the management of brain metastases","volume":"18","author":"Arvold","year":"2016","journal-title":"Neuro Oncol"},{"key":"2026101519013117900_vdag228-B3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-019-03171-6","article-title":"Survival and prognostic factors in surgically treated brain metastases","volume":"143","author":"Kavouridis","year":"2019","journal-title":"J Neurooncol"},{"key":"2026101519013117900_vdag228-B4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: a society for neuro-oncology (SNO) consensus review on current management and future directions","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro Oncol"},{"key":"2026101519013117900_vdag228-B5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/jco.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026101519013117900_vdag228-B6","doi-asserted-by":"publisher","first-page":"Jco2018786186","DOI":"10.1200\/jco.2018.78.6186","article-title":"Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase III, noninferiority, randomized controlled trial","volume":"36","author":"Kayama","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026101519013117900_vdag228-B7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/s1470-2045(17)30414-x","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026101519013117900_vdag228-B8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/s1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026101519013117900_vdag228-B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3171\/2009.11.Jns09659","article-title":"Factors influencing the risk of local recurrence after resection of a single brain metastasis","volume":"113","author":"Patel","year":"2010","journal-title":"J Neurosurg"},{"key":"2026101519013117900_vdag228-B10","doi-asserted-by":"publisher","first-page":"vdad007","DOI":"10.1093\/noajnl\/vdad007","article-title":"CDKN2A\/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases","volume":"5","author":"Morshed","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026101519013117900_vdag228-B11","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2023.5.Focus23214","article-title":"Genomic alterations associated with rapid progression of brain metastases","volume":"55","author":"Uggerly","year":"2023","journal-title":"Neurosurg Focus"},{"key":"2026101519013117900_vdag228-B12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2008.04.070","article-title":"Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases","volume":"73","author":"Do","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026101519013117900_vdag228-B13","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1038\/s41598-019-43942-9","article-title":"Risk factors for in-brain local progression in elderly patients after resection of cerebral metastases","volume":"9","author":"Munoz-Bendix","year":"2019","journal-title":"Sci Rep"},{"key":"2026101519013117900_vdag228-B14","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1158\/1078-0432.Ccr-13-3003","article-title":"Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target","volume":"20","author":"Chen","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2026101519013117900_vdag228-B15","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/bcr3150","article-title":"Relevance of PTEN loss in brain metastasis formation in breast cancer patients","volume":"14","author":"Wikman","year":"2012","journal-title":"Breast Cancer Res"},{"key":"2026101519013117900_vdag228-B16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"key":"2026101519013117900_vdag228-B17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.Cd-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"key":"2026101519013117900_vdag228-B18","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/neuonc\/noad098","article-title":"A genomic score to predict local control among patients with brain metastases managed with radiation","volume":"25","author":"Lamba","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026101519013117900_vdag228-B19","doi-asserted-by":"publisher","first-page":"215870","DOI":"10.1016\/j.canlet.2022.215870","article-title":"Novel insights into RB1 mutation","volume":"547","author":"Yao","year":"2022","journal-title":"Cancer Lett"},{"key":"2026101519013117900_vdag228-B20","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.18632\/oncotarget.2848","article-title":"Cyclin alterations in diverse cancers: outcome and co-amplification network","volume":"6","author":"Schwaederl\u00e9","year":"2015","journal-title":"Oncotarget"},{"key":"2026101519013117900_vdag228-B21","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","article-title":"TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma","volume":"20","author":"Spiegl-Kreinecker","year":"2018","journal-title":"Neuro Oncol"},{"key":"2026101519013117900_vdag228-B22","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1158\/1078-0432.Ccr-17-3717","article-title":"TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas: a pilot prospective study","volume":"24","author":"Juratli","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026101519013117900_vdag228-B23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/eje-14-0837","article-title":"TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma","volume":"172","author":"Gandolfi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026101519013117900_vdag228-B24","doi-asserted-by":"publisher","first-page":"808298","DOI":"10.3389\/fendo.2022.808298","article-title":"TERT promoter mutations are an independent predictor of distant metastasis in Middle Eastern papillary thyroid microcarcinoma","volume":"13","author":"Parvathareddy","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026101519013117900_vdag228-B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082224","article-title":"TERT promoter mutation as an independent prognostic marker for poor prognosis MAPK inhibitors-treated melanoma","volume":"12","author":"Blateau","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026101519013117900_vdag228-B26","doi-asserted-by":"publisher","first-page":"6300329","DOI":"10.1155\/2022\/6300329","article-title":"TERT promoter mutations and telomerase in melanoma","volume":"2022","author":"Guo","year":"2022","journal-title":"J Oncol"},{"key":"2026101519013117900_vdag228-B27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2026101519013117900_vdag228-B28","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science (1979)"},{"key":"2026101519013117900_vdag228-B29","first-page":"5833","article-title":"The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers","volume":"11","author":"Wang","year":"2021","journal-title":"Am J Cancer Res"},{"key":"2026101519013117900_vdag228-B30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2741\/1592","article-title":"AKT\/PKB signaling mechanisms in cancer and chemoresistance","volume":"10","author":"Kim","year":"2005","journal-title":"Front Biosci"},{"key":"2026101519013117900_vdag228-B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147817","article-title":"PTEN depletion increases radiosensitivity in response to ataxia Telangiectasia-Related-3 (ATR) inhibition in non-small cell lung cancer (NSCLC)","volume":"25","author":"Dunne","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026101519013117900_vdag228-B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112876","article-title":"PTEN loss enhances error-prone DSB processing and tumor cell radiosensitivity by suppressing RAD51 expression and homologous recombination","volume":"23","author":"Pei","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026101519013117900_vdag228-B33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccell.2019.01.020","article-title":"Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair","volume":"35","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"2026101519013117900_vdag228-B34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/1078-0432.Ccr-11-3131","article-title":"Does PTEN loss impair DNA double-strand break repair by homologous recombination?","volume":"18","author":"Hunt","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2026101519013117900_vdag228-B35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/JTO.0b013e3182641d4f","article-title":"Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma","volume":"7","author":"Yanagawa","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2026101519013117900_vdag228-B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40880-019-0354-z","article-title":"Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations","volume":"39","author":"Wang","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"2026101519013117900_vdag228-B37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/nejm199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"2026101519013117900_vdag228-B38","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00701-021-05104-7","article-title":"Surgery for brain metastases-impact of the extent of resection","volume":"164","author":"Winther","year":"2022","journal-title":"Acta Neurochir (Wien)"},{"key":"2026101519013117900_vdag228-B39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00701-013-1619-y","article-title":"The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study","volume":"155","author":"Lee","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"2026101519013117900_vdag228-B40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1227\/neu.0000000000003544","article-title":"Impact of extent of resection on survival in brain metastasis: an analysis of 867 patients","volume":"98","author":"Hulsbergen","year":"2026","journal-title":"Neurosurgery"},{"key":"2026101519013117900_vdag228-B41","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/j.wneu.2022.08.066","article-title":"Risk factors of second local recurrence in surgically treated recurrent brain metastases: an exploratory analysis","volume":"167","author":"Tewarie","year":"2022","journal-title":"World Neurosurg"},{"key":"2026101519013117900_vdag228-B42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jtho.2023.03.004","article-title":"Systemic treatment for brain metastases in NSCLC: a new chapter","volume":"18","author":"Acker","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026101519013117900_vdag228-B43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ijc.33243","article-title":"Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience","volume":"148","author":"Gao","year":"2021","journal-title":"Int J Cancer"},{"key":"2026101519013117900_vdag228-B44","doi-asserted-by":"publisher","first-page":"854402","DOI":"10.3389\/fonc.2022.854402","article-title":"Improving brain metastases outcomes through therapeutic synergy between stereotactic radiosurgery and targeted cancer therapies","volume":"12","author":"Rubino","year":"2022","journal-title":"Front Oncol"},{"key":"2026101519013117900_vdag228-B45","doi-asserted-by":"publisher","first-page":"110540","DOI":"10.1016\/j.radonc.2024.110540","article-title":"Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments","volume":"200","author":"van Schie","year":"2024","journal-title":"Radiother Oncol"},{"key":"2026101519013117900_vdag228-B46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11060-023-04343-1","article-title":"Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series","volume":"163","author":"van Schie","year":"2023","journal-title":"J Neurooncol"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag228\/71840227\/vdag228.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag228\/71840227\/vdag228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag228\/71840227\/vdag228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:01:37Z","timestamp":1792105297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag228\/8907469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag228","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag228"}}